Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02709889
Brief Title: Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

First Submitted : March 2, 2016
First Submitted that Met QC Criteria : March 10, 2016
First Posted : March 16, 2016 (Estimate)

Results First Submitted : August 11, 2020
Results First Submitted that Met QC Criteria : September 21, 2020
Results First Posted : October 19, 2020

Last Update Submitted that Met QC Criteria : September 21, 2020
Last Update Posted : October 19, 2020